IO Biotech, Inc. (IOBT)
NASDAQ: IOBT · Real-Time Price · USD
0.7516
-0.0734 (-8.90%)
At close: Nov 19, 2025, 4:00 PM EST
0.7562
+0.0046 (0.61%)
Pre-market: Nov 20, 2025, 4:55 AM EST
IO Biotech Market Cap
IO Biotech has a market cap or net worth of $49.52 million as of November 20, 2025. Its market cap has decreased by -36.31% in one year.
Market Cap
49.52M
Enterprise Value
36.97M
1-Year Change
-36.31%
Ranking
Category
Stock Price
$0.75
Market Cap Chart
Since the IPO on November 5, 2021, IO Biotech's market cap has decreased from $369.28M to $49.52M, a decrease of -86.59%. That is a compound annual growth rate of -39.18%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 19, 2025 | 49.52M | -18.30% |
| Dec 31, 2024 | 60.61M | -51.06% |
| Dec 29, 2023 | 123.86M | 86.88% |
| Dec 30, 2022 | 66.28M | -64.06% |
| Dec 31, 2021 | 184.42M | -50.06% |
| Nov 5, 2021 | 369.28M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 914.81B |
| Johnson & Johnson | 480.85B |
| AbbVie | 413.57B |
| UnitedHealth Group | 290.34B |
| AstraZeneca | 277.65B |
| Novartis AG | 255.14B |
| Merck & Co. | 230.48B |
| Abbott Laboratories | 226.11B |